Contracts › 75N93023C00048
75N93023C00048: Advanced Development of Lq a Liposome-Based Saponin-Containing Adjuvant for Use in Pansarbecovirus Vaccines
Awarded to Institut De Formulation Des Vaccins (Ch) Sa by National Institutes of Health (NIH).
$8.2Mobligated
$8.2Mpotential value
30 September 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N93023C00048 |
|---|---|
| Awardee | Institut De Formulation Des Vaccins (Ch) Sa |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541512 Computer Systems Design Services |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Offers received | 24 |
| Period of performance | 30 September 2023 to 30 September 2027 |
| Potential end | 29 September 2028 |
| Estimated recompete solicitation | ~Q2 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541512 contracts · All expiring contracts · USASpending record